Page last updated: 2024-10-29

iohexol and Arteriosclerosis Obliterans

iohexol has been researched along with Arteriosclerosis Obliterans in 1 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Arteriosclerosis Obliterans: Common occlusive arterial disease which is caused by ATHEROSCLEROSIS. It is characterized by lesions in the innermost layer (ARTERIAL INTIMA) of arteries including the AORTA and its branches to the extremities. Risk factors include smoking, HYPERLIPIDEMIA, and HYPERTENSION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tsuruta, S1
Matayoshi, H1
Nagamizo, D1
Morimoto, Y1
Sakabe, T1

Reviews

1 review available for iohexol and Arteriosclerosis Obliterans

ArticleYear
[Case of electrocardiogram showing ST depression after nonionic contrast media (iopromide) administration].
    Masui. The Japanese journal of anesthesiology, 2008, Volume: 57, Issue:2

    Topics: Aged; Anesthesia, General; Arteriosclerosis Obliterans; Contrast Media; Coronary Stenosis; Electroca

2008